豐元股份(002805.SZ)半年度預盈2000萬-2400萬元
格隆匯7月13日丨豐元股份(002805.SZ)公佈,預計2021年半年度歸屬於上市公司股東的淨利潤2000萬元-2400萬元,上年同期盈利341.43萬元;扣除非經常性損益後的淨利潤1900萬元-2300萬元,上年同期虧損96.98萬元。
報吿期內,受下游行業快速增長帶動,公司重點發展的新能源鋰電池正極材料產業迎來歷史性機遇,公司正極材料產品銷售收入較去年同期相比快速增長,同時公司管理團隊在原材料價格等成本管控、技術升級以更好滿足客户及市場需求方面採取了積極有效的措施以提升盈利水平,2021年上半年,公司總體經營業績較上年同期有明顯改善和提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.